Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Candel Therapeutics, Inc. Capital/Financing Update 2021

Jul 26, 2021

33336_rns_2021-07-26_84121081-867c-4540-a844-f4070efaef5d.zip

Capital/Financing Update

Open in viewer

Opens in your device viewer

CORRESP 1 filename1.htm Underwriter Acceleration Request

Jefferies LLC 520 Madison Avenue New York, New York 10022 Credit Suisse Securities (USA) LLC Eleven Madison Avenue New York, New York 10010 BMO Capital Markets Corp. 3 Times Square, 24th Floor New York, New York 10036 UBS Securities LLC 1285 Avenue of the Americas 10th Floor New York, New York 10019

VIA EDGAR

July 26, 2021

United States Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences

100 F Street, N.E.

Washington, D.C. 20549

Attention: David Gessert

Celeste Murphy

Re: Candel Therapeutics, Inc.

Acceleration Request for Registration Statement on Form S-1

File No. 333-257444

Dear Mr. Gessert and Ms. Murphy,

Pursuant to Rule 460 of the General Rules and Regulations under the Securities Act of 1933, as amended (the “ Act ”), we, as representatives of the several underwriters, wish to advise you that approximately 2,000 copies of the preliminary prospectus included in the above-named registration statement (the “ Registration Statement ”) were distributed during the period July 16, 2021 through the date hereof, to prospective underwriters, institutions, dealers and others.

We have been informed by the participating underwriters that they will comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.

In accordance with Rule 461 of the Act, we hereby join in the request of Candel Therapeutics, Inc. for acceleration of the effective date of the Registration Statement so that it becomes effective at 4:00 p.m. Eastern Time on July 26, 2021, or as soon thereafter as practicable.

[ Remainder of page intentionally left blank ]

Very truly yours,
By: JEFFERIES LLC
By: /s/ Matt Kim
Name: Matt Kim
Title: Managing Director
By: CREDIT SUISSE SECURITIES (USA) LLC
By: /s/ Rebecca Kotkin
Name: Rebecca Kotkin
Title: Director
By: BMO CAPITAL MARKETS CORP.
By: /s/ Annette Grimaldi
Name: Annette Grimaldi
Title: Managing Director
By: UBS SECURITIES LLC
By: /s/ Arun Master
Name: Arun Master
Title: Managing Director
By: UBS SECURITIES LLC
By: /s/ Christian Parrish
Name: Christian Parrish
Title: Director

[ Signature Page to Acceleration Request Letter ]